Publications

5808 Results

SWOG S0353: Phase II trial of intravesical gemcitabine in patients with non-muscle invasive bladder cancer who recurred following at least two prior courses of bacillus Calmette-Guérin

Authors
E Skinner;B Goldman;W Sakr;D Petrylak;H Lenz;CT Lee;S Wilson;M Benson;SP Lerner;CM Tangen;IM Thompson
Journal / Conference
Journal of Urology 190(4):1200-1204;
Year
2013
Research Committee(s)
Genitourinary
PMID
PMID23597452
PMC
PMC4113593
Study Number(s)
S0353

Gene expression-based model using formalin-fixed paraffin-embedded biopsies predicts overall survival in advanced stage classical hodgkin lymphoma

Authors
DW Scott;FC Chan;F Hong;S Rogic;K Tan;B Meissner;S Ben-Neriah;M Boyle;R Kridel;A Telenius;B Woolcock;P Farinha;RI Fisher;L Rimsza;NL Bartlett;LE Shepherd;RH Advani;JM Connors;B Kahl;LI Gordon;SJ Horning;R Gascoyne
Journal / Conference
Journal of Clinical Oncology 31(6):692-700;
Year
2013
Research Committee(s)
Lymphoma
PMID
PMID23182984
PMC
PMC3574267
Study Number(s)
E2496

A randomized phase III trial of ABVD vs. Stanford V +/- radiation therapy in locally extensive and advanced stage hodgkin lymphoma: an intergroup study coordinated by the Eastern Cooperative Oncology Group (E2496)

Authors
L Gordon;F Hong;RI Fisher;NL Bartlett;JM Connors;R Gascoyne;H Wagner;P Stiff;B Cheson;M Gospodarowicz;R Advani;B Kahl;J Friedberg;K Blum;T Habermann;J Tuscano;RT Hoppe;SJ Horning
Journal / Conference
Journal of Clinical Oncology 31(6):684-691;
Year
2013
Research Committee(s)
Lymphoma
PMID
PMID23182987
PMC
PMC3574266
Study Number(s)
E2496

Outcome of adolescents and young adults with acute myeloid leukemia treated on COG trials compared to CALGB and SWOG trials

Authors
WG Woods;AR Franklin;TA Alonzo;RB Gerbing;KA Donohue;M Othus;J Horan;FR Appelbaum;EH Estey;CD Bloomfield;RA Larson
Journal / Conference
Cancer 119(23):4170-4179;
Year
2013
Research Committee(s)
Leukemia
PMID
PMID24104597
PMC
PMC3833872
Study Number(s)
S0106, SWOG-8600, SWOG-9500

Randomized double-blind placebo-controlled trial of acetyl-l-carnitine for the prevention of taxane induced neuropathy in women undergoing adjuvant breast cancer therapy

Authors
D Hershman;J Unger;K Crew;L Minasian;C Moinpour;L Hansen;DL Lew;L Fehrenbacher;JL Wade;S Wong;G Hortobagyi;F Meyskens;K Albain
Journal / Conference
Journal of Clinical Oncology 31(20):2627-2633;
Year
2013
Research Committee(s)
Symptom Management and Survivorship
PMID
PMID23733756
PMC
PMC3699727
Study Number(s)
S0715

Integrating comparative effectiveness design elements and endpoints into a phase III, randomized clinical trial (SWOG S1007) evaluating OncotypeDX-guided management for women with breast cancer involving lymph nodes

Authors
S Ramsey;W Barlow;A Gonzalez-Angulo;S Tunis;L Baker;J Crowley;P Deverka;D Veenstra;G Hortobagyi
Journal / Conference
Contemporary Clinical Trials 34(1):1-9;
Year
2013
Research Committee(s)
Breast
PMID
PMID23000081
PMC
PMC3525786
Study Number(s)
S1007

Plasma Epstein-Barr viral DNA as a marker of tumor response in Hodgkin lymphoma

Authors
JA Kanakry;H Li;LL Gellert;MV Lemas;W Hsieh;F Hong;KL Tan;R Gascoyne;LI Gordon;RI Fisher;NL Bartlett;P Stiff;B Cheson;R Advani;L Rimsza;B Kahl;SJ Horning
Journal / Conference
Blood 121(18):3547-3553;
Year
2013
Research Committee(s)
Lymphoma
PMID
PMID23386127
PMC
PMC3643756
Study Number(s)
E2496

Patient income level and cancer clinical trial participation

Authors
J Unger;DL Hershman;K Albain;CM Moinpour;JA Petersen;K Burg;JJ Crowley
Journal / Conference
Journal of Clinical Oncology 31(5):536-542;
Year
2013
Research Committee(s)
Cancer Care Delivery and Outcomes and Comparative Effectiveness
PMID
PMID23295802
PMC
PMC3565180

The efficacy and tolerability of ABVD and Stanford V in older hodgkin lymphoma patients: a comprehensive analysis from the North American intergroup trial E2496

Authors
AM Evens;F Hong;L Gordon;RI Fisher;P Stiff;T Miller;N Bartlett;J Connors;R Gascoyne;H Wagner;M Gospodarowicz;B Cheson;R Advani;R Hoppe;B Kahl;S Horning
Journal / Conference
British Journal of Haematology 161(1):76-86;
Year
2013
Research Committee(s)
Lymphoma
PMID
PMID23356491
PMC
PMC3906856
Study Number(s)
E2496

Implementation of timeline reforms significantly speeds up initiation of NCI-sponsored trials

Authors
JS Abrams;M Mooney;J Zwiebel;G Hortobagyi;S Friedman;S Finnigan;P Schettino;A Denicoff;M Kruhm;M Montello;R Misra;S Ansher;K DiPiazza;E Souhan;L Wickerham;PJ Giantonio;R O'Donnell;DM Sullivan;N Soto;G Fleming;S Prindiville;RA Petryshyn;J Hautala;O Grad;RM Meyer;JC Yao;LH Baker;J Buckner;J Doroshow
Journal / Conference
Journal of the National Cancer Institute 105(13):954-959;
Year
2013
Research Committee(s)
Cancer Care Delivery and Multiple sites
PMID
PMID23776198
PMC
PMC3699438